Addressing Involuntary Movements in Tardive Dyskinesia
Public ClinicalTrials.gov record NCT02291861. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether fixed-doses of an investigational drug, SD-809 (deutetrabenazine), will reduce the severity of abnormal involuntary movements of tardive dyskinesia.
Study identification
- NCT ID
- NCT02291861
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 298 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2014 (Actual)
- Primary completion
- Aug 19, 2016 (Actual)
- Completion
- Aug 19, 2016 (Actual)
- Last update posted
- Jun 23, 2026
2014 – 2016
United States locations
- U.S. sites
- 53
- U.S. states
- 24
- U.S. cities
- 46
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Teva Investigational Site 145 | Tuscaloosa | Alabama | 35404 | — |
| Teva Investigational Site 107 | Anaheim | California | 92804 | — |
| Teva Investigational Site 108 | Anaheim | California | 92805 | — |
| Teva Investigational Site 123 | Glendale | California | 91206 | — |
| Teva Investigational Site 177 | Imperial | California | 92251 | — |
| Teva Investigational Site 160 | Irvine | California | 92614 | — |
| Teva Investigational Site 106 | Irvine | California | 92697 | — |
| Teva Investigational Site 176 | Loma Linda | California | 92354 | — |
| Teva Investigational Site 121 | Los Angeles | California | 90033 | — |
| Teva Investigational Site 147 | Los Angeles | California | 90095-1769 | — |
| Teva Investigational Site 174 | Norwalk | California | 90650 | — |
| Teva Investigational Site 170 | Oceanside | California | 92056 | — |
| Teva Investigational Site 102 | Orange | California | 92868 | — |
| Teva Investigational Site 104 | San Bernardino | California | 92408 | — |
| Teva Investigational Site 110 | San Diego | California | 92108 | — |
| Teva Investigational Site 169 | San Rafael | California | 94901 | — |
| Teva Investigational Site 129 | Englewood | Colorado | 80113 | — |
| Teva Investigational Site 139 | New Haven | Connecticut | 06519 | — |
| Teva Investigational Site 156 | Washington D.C. | District of Columbia | 20007 | — |
| Teva Investigational Site 157 | Boca Raton | Florida | 33486 | — |
| Teva Investigational Site 117 | Gainesville | Florida | 32607 | — |
| Teva Investigational Site 150 | Lake City | Florida | 32025 | — |
| Teva Investigational Site 153 | Miami | Florida | 33135 | — |
| Teva Investigational Site 162 | Miami | Florida | 33165 | — |
| Teva Investigational Site 112 | Orlando | Florida | 32803 | — |
| Teva Investigational Site 144 | Port Charlotte | Florida | 33980 | — |
| Teva Investigational Site 155 | Augusta | Georgia | 30912 | — |
| Teva Investigational Site 165 | Decatur | Georgia | 30033 | — |
| Teva Investigational Site 131 | Chicago | Illinois | 60611 | — |
| Teva Investigational Site 113 | Chicago | Illinois | 60612 | — |
| Teva Investigational Site 164 | Kansas City | Kansas | 66160 | — |
| Teva Investigational Site 154 | Baltimore | Maryland | 21287 | — |
| Teva Investigational Site 101 | Glen Burnie | Maryland | 21061 | — |
| Teva Investigational Site 135 | Boston | Massachusetts | 02215 | — |
| Teva Investigational Site 118 | Creve Coeur | Missouri | 63141 | — |
| Teva Investigational Site 142 | Kansas City | Missouri | 64108 | — |
| Teva Investigational Site 175 | St Louis | Missouri | 63104 | — |
| Teva Investigational Site 161 | St Louis | Missouri | 63109 | — |
| Teva Investigational Site 178 | Lincoln | Nebraska | 68526-9467 | — |
| Teva Investigational Site 128 | Albuquerque | New Mexico | 87106 | — |
| Teva Investigational Site 172 | Commack | New York | 11725 | — |
| Teva Investigational Site 148 | New York | New York | 10032 | — |
| Teva Investigational Site 138 | Asheville | North Carolina | 28805 | — |
| Teva Investigational Site 146 | Raleigh | North Carolina | 27610 | — |
| Teva Investigational Site 133 | Charleston | South Carolina | 29425 | — |
| Teva Investigational Site 149 | Memphis | Tennessee | 38163 | — |
| Teva Investigational Site 151 | Fort Worth | Texas | 76104 | — |
| Teva Investigational Site 115 | Salt Lake City | Utah | 84105 | — |
| Teva Investigational Site 141 | Salt Lake City | Utah | 84108 | — |
| Teva Investigational Site 168 | Burlington | Vermont | 05401 | — |
| Teva Investigational Site 171 | Charlottesville | Virginia | 22903 | — |
| Teva Investigational Site 167 | Richland | Washington | 99352 | — |
| Teva Investigational Site 166 | Waukesha | Wisconsin | 53188 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 53 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02291861, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 23, 2026 · Synced Nov 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02291861 live on ClinicalTrials.gov.